Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.47 |
| ▸ | CD40 | P25942 | 3/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 7/20 | 0.46 |
| ▸ | F2 | P00734 | 4/20 | 0.44 |
| ▸ | MC4R | P32245 | 1/20 | 0.44 |
| ▸ | APC | P25054 | 1/20 | 0.44 |
| ▸ | GLP1R | P43220 | 2/20 | 0.43 |
| ▸ | SCTR | P47872 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29582481 | 0.90 | NAALAD2 (0.46) | OPRM1OPRD1F2APC | |
| SCHEMBL31031530 | 0.90 | OPRD1 (0.48) | C5AR1OPRM1OPRD1F2GLP1R | |
| SCHEMBL31694488 | 0.90 | C5AR1 (0.58) | C5AR1MC4RGLP1RSCTR | |
| SCHEMBL29536767 | 0.90 | C5AR1 (0.56) | C5AR1F2GLP1R | |
| SCHEMBL30536318 | 0.87 | F2 (0.58) | F2GLP1R | |
| SCHEMBL6824254 | 0.86 | LNPEP (0.47) | C5AR1OPRM1OPRD1 | |
| SCHEMBL6824252 | 0.86 | LNPEP (0.47) | C5AR1OPRM1OPRD1 | |
| SCHEMBL29800072 | 0.86 | F2 (0.46) | C5AR1F2GLP1RSCTR | |
| SCHEMBL31419818 | 0.85 | NPY4R (0.46) | C5AR1 | |
| SCHEMBL30688994 | 0.84 | NAALAD2 (0.52) | OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114409730-A | Active peptide, active peptide composition and application of active peptide composition in preparation of product with anti-aging effect | 深圳科兴药业有限公司 | 2022-04-29 | — | — | CN | disclosed |